insights from industryJack O'Meara Co-Founder and CEOOchre-Bio In this interview, we speak with Jack O'Meara, co-founder and CEO of Ochre Bio, a pioneering force in liver disease treatment. O'Meara ...

Macrophages are considered the "scavenger cells" of the immune system, but some pathogens exploit these very cells as hiding ...

"Gene-editing scissors directly intervene in the DNA, which is the cell's original blueprint. This means a single misstep could result in permanent si ...

When a gene is expressed, its DNA sequence is transcribed into a molecule known as RNA. Then the cell processes and edits that RNA before it is translated into protein. Many genes can be processed and ...

Over the past few years, the excitement over genome editing has moved well beyond the original CRISPR-Cas system described a decade ago, into areas such as the discovery of new Cas systems, CRISPR ...

There are many molecules with therapeutic potential, but it can be a challenge to deliver them to the right places at the right times. RNA is one such molecule; the sequences for different proteins ...

Scientists at Université de Montréal's Institute for Research in Immunology and Cancer have developed a new database that integrates the molecular structure of microRNAs and messenger RNAs to ...

Amber Bio’s proprietary platform leverages multi-kilobase RNA editing and AI foundation models to expand the reach of treatable pathogenic variants SAN FRANCISCO--(BUSINESS WIRE)--Amber Bio, a ...

In recent decades, significant advances in science and technology have greatly enhanced understanding of the many biological molecules that contribute to life’s complexity. RNA is one such molecule ...

The enzyme tRNA-guanine transglycosylase (TGT) chemically modifies transfer RNA (tRNA) and plays a key role in how ...